Vitamin C Administration and Triglycerides Level in Critical Care Patients

Launched by MEIR MEDICAL CENTER · Jan 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether giving vitamin C to critically ill patients can help lower high triglyceride (TG) levels. High TG levels can lead to serious complications, especially in intensive care patients who may have conditions like infections, liver problems, or diabetes. In the past, some studies suggested that vitamin C could lower TG levels in other patients, but there hasn't been research on its effects specifically in critically ill patients. The trial will compare patients who receive vitamin C with those who do not to see if it makes a difference in managing TG levels and preventing complications.

To participate in this trial, individuals must be between 18 and 99 years old and have been admitted to the general intensive care unit from January 2017 to December 2023. The study will include those who received intravenous vitamin C and a control group of patients who did not receive this treatment. Participants can expect to be monitored closely while receiving care in the intensive care unit, and the study aims to provide more information on the potential benefits of vitamin C in this setting.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: patients aged 18-99 who were admitted to the general intensive care unit from January 2017 to December 2023, and who were treated with intravenous vitamin C. The control group will include patients with the same characteristics who were not treated with vitamin C.
• • Exclusion criteria: patients who did not meet the above conditions or for whom data were missing.
• • -
• • -